Ai Yoshimi

633 total citations
15 papers, 235 citations indexed

About

Ai Yoshimi is a scholar working on Public Health, Environmental and Occupational Health, Hematology and Molecular Biology. According to data from OpenAlex, Ai Yoshimi has authored 15 papers receiving a total of 235 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Public Health, Environmental and Occupational Health, 4 papers in Hematology and 3 papers in Molecular Biology. Recurrent topics in Ai Yoshimi's work include Acute Lymphoblastic Leukemia research (4 papers), Childhood Cancer Survivors' Quality of Life (3 papers) and Acute Myeloid Leukemia Research (2 papers). Ai Yoshimi is often cited by papers focused on Acute Lymphoblastic Leukemia research (4 papers), Childhood Cancer Survivors' Quality of Life (3 papers) and Acute Myeloid Leukemia Research (2 papers). Ai Yoshimi collaborates with scholars based in Japan and United States. Ai Yoshimi's co-authors include Motoo Tsushima, Yasuko Nakano, Motowo Tomita, Takaharu Negoro, Haruyo Akiyama, Takashi Tobe, Toshihiro Tanioka, Keisuke Kato, Kazutoshi Koike and Masahiro Tsuchida and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Lipid Research and Annals of Hematology.

In The Last Decade

Ai Yoshimi

15 papers receiving 230 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ai Yoshimi Japan	9	101	55	52	51	47	15	235
Tsutomu Ishizuka Japan	9	64 0.6×	68 1.2×	61 1.2×	48 0.9×	28 0.6×	15	496
László Csáthy Hungary	11	72 0.7×	67 1.2×	31 0.6×	76 1.5×	30 0.6×	25	362
Yekta Tüzün Türkiye	11	63 0.6×	31 0.6×	23 0.4×	41 0.8×	28 0.6×	21	403
Daniel Elías-López Mexico	8	79 0.8×	74 1.3×	35 0.7×	31 0.6×	20 0.4×	21	297
Rocío Puig Spain	7	44 0.4×	135 2.5×	17 0.3×	21 0.4×	97 2.1×	17	315
Rizk Elbaz Egypt	12	35 0.3×	20 0.4×	19 0.4×	46 0.9×	62 1.3×	31	320
Véronique Remones France	8	28 0.3×	23 0.4×	68 1.3×	69 1.4×	49 1.0×	11	307
Jaskamal Padda United States	12	32 0.3×	17 0.3×	23 0.4×	26 0.5×	26 0.6×	23	255
Mehmet Akif Özdemir Türkiye	10	36 0.4×	27 0.5×	18 0.3×	10 0.2×	78 1.7×	34	272
Michael P. Gruber United States	6	125 1.2×	20 0.4×	14 0.3×	97 1.9×	76 1.6×	9	301

Countries citing papers authored by Ai Yoshimi

Since Specialization

Citations

This map shows the geographic impact of Ai Yoshimi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ai Yoshimi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ai Yoshimi more than expected).

Fields of papers citing papers by Ai Yoshimi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ai Yoshimi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ai Yoshimi. The network helps show where Ai Yoshimi may publish in the future.

Co-authorship network of co-authors of Ai Yoshimi

This figure shows the co-authorship network connecting the top 25 collaborators of Ai Yoshimi. A scholar is included among the top collaborators of Ai Yoshimi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ai Yoshimi. Ai Yoshimi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Kato, Keisuke, Jun‐ichi Nagai, Hiroaki Goto, et al.. (2024). Establishment and characterization of a novel MDM2/MYCN-co-amplified neuroblastoma cell line, NBN-SHIM, established from a late recurrent stage MS tumor. Human Cell. 37(5). 1602–1609. 1 indexed citations

Yoshimi, Ai, Takayuki Masuko, Keisuke Kato, et al.. (2023). Successful Treatment for Hepatoblastoma in Trisomy 18: A Case Report. Journal of Pediatric Hematology/Oncology. 46(1). e83–e86. 3 indexed citations

Kato, Keisuke, et al.. (2022). Pernicious anemia associated with Kabuki syndrome. Pediatrics International. 64(1). e14960–e14960. 2 indexed citations

Yoshimi, Ai, Norihiko Kitagawa, Masato Shinkai, et al.. (2020). Multi-disciplinary treatment of undifferentiated embryonal sarcoma of the liver with tumor embolus extending to the heart. SHILAP Revista de lepidopterología. 66. 101705–101705. 1 indexed citations

Yoshimi, Ai, et al.. (2019). Primary Cutaneous Diffuse Large B-Cell Lymphoma With KMT2A-MLLT3: An Infantile Case Study. Journal of Pediatric Hematology/Oncology. 41(8). 657–658. 1 indexed citations

Suzuki, Hisato, Hiroko Fukushima, Chie Kobayashi, et al.. (2016). Genotyping NUDT15 can predict the dose reduction of 6-MP for children with acute lymphoblastic leukemia especially at a preschool age. Journal of Human Genetics. 61(9). 797–801. 25 indexed citations

Kato, Keisuke, Junko Takita, Yuji Gunji, et al.. (2015). Molecular genetic and cytogenetic analysis of a primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma. International Journal of Hematology. 103(2). 196–201. 11 indexed citations

Suzuki, Ryoko, Hiroko Fukushima, Masahiro Tsuchida, et al.. (2015). Influence of SLCO1B1 polymorphism on maintenance therapy for childhood leukemia. Pediatrics International. 57(4). 572–577. 12 indexed citations

Fukushima, Hiroko, Takashi Fukushima, Aiko Sakai, et al.. (2013). Polymorphisms of MTHFR Associated with Higher Relapse/Death Ratio and Delayed Weekly MTX Administration in Pediatric Lymphoid Malignancies. PubMed. 2013. 1–9. 11 indexed citations

10.

Fukushima, Hiroko, Takashi Fukushima, Ryoko Suzuki, et al.. (2012). Central nervous system lesions due to juvenile myelomonocytic leukemia progressed in a boy undergoing first line chemotherapy. International Journal of Hematology. 95(5). 581–584. 1 indexed citations

11.

Kato, Keisuke, Yasuko Kojima, Chie Kobayashi, et al.. (2011). Successful allogeneic hematopoietic stem cell transplantation for chronic granulomatous disease with inflammatory complications and severe infection. International Journal of Hematology. 94(5). 479–482. 21 indexed citations

12.

Kato, Keisuke, Chie Kobayashi, Junko Shiono, et al.. (2010). Transient abnormal myelopoiesis in a cytogenetically normal neonate. International Journal of Hematology. 92(3). 527–530. 8 indexed citations

13.

Enami, Terukazu, Takeshi Suzuki, Satoshi Ito, et al.. (2007). Successful Treatment of Refractory Thrombotic Thrombocytopenic Purpura with Cyclosporine and Corticosteroids in a Patient with Systemic Lupus Erythematosus and Antibodies to ADAMTS13. Internal Medicine. 46(13). 1033–1037. 10 indexed citations

14.

Nakano, Yasuko, Ai Yoshimi, Haruyo Akiyama, et al.. (2006). A novel enzyme-linked immunosorbent assay specific for high-molecular-weight adiponectin. Journal of Lipid Research. 47(7). 1572–1582. 108 indexed citations

15.

Komatsu, Tsunehiko, Hiroto Narimatsu, Ai Yoshimi, et al.. (2006). Successful engraftment of mismatched unrelated cord blood transplantation following reduced intensity preparative regimen using fludarabine and busulfan. Annals of Hematology. 86(1). 49–54. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact